Skip to main content
Erschienen in: Trials 1/2020

Open Access 08.06.2020 | COVID-19 | Letter

Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial

verfasst von: Magnus Nakrem Lyngbakken, Jan-Erik Berdal, Arne Eskesen, Dag Kvale, Inge Christoffer Olsen, Anbjørg Rangberg, Christine Monceyron Jonassen, Torbjørn Omland, Helge Røsjø, Olav Dalgard

Erschienen in: Trials | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial
verfasst von
Magnus Nakrem Lyngbakken
Jan-Erik Berdal
Arne Eskesen
Dag Kvale
Inge Christoffer Olsen
Anbjørg Rangberg
Christine Monceyron Jonassen
Torbjørn Omland
Helge Røsjø
Olav Dalgard
Publikationsdatum
08.06.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04420-0

Weitere Artikel der Ausgabe 1/2020

Trials 1/2020 Zur Ausgabe